|
| 可孚医疗(301087)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-04-25 | 11279.54 | 53.91% | 20356.47 | 567.35 | 9057.43 | 43.29% | 追加承诺限售股份上市流通 | | 2025-02-24 | 19.50 | 0.09% | 9076.93 | 11846.89 | 9057.43 | 43.29% | 股权激励限售股份 | | 2023-10-31 | 69.96 | 0.34% | 8982.36 | 11866.39 | 8987.48 | 43.11% | 股权激励一般股份 | | 2023-10-25 | 151.84 | 0.73% | 8987.48 | 11861.27 | 8835.64 | 42.38% | 首发战略配售股份,股权激励限售股份 | | 2023-06-08 | 181.72 | 0.87% | 8835.64 | 12013.11 | 8653.91 | 41.51% | 追加承诺限售股份上市流通 | | 2022-10-28 | 3593.56 | 17.24% | 8689.02 | 12159.73 | 8689.02 | 41.68% | 首发原股东限售股份 | | 2022-04-25 | 197.68 | 1.23% | 3900.09 | 12137.41 | 3900.09 | 24.32% | 首发机构配售股份 |
|